A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme.
about
Combating poor-quality anti-malarial medicines: a call to actionViewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern MalawiMedicines for cancers in children: The WHO model for selection of essential medicines.The Global Drug Facility as an intervention in the market for tuberculosis drugsTough decisions on essential medicines in 2015.Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market AuthorizationThe prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians.Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility.Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpointFighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy.Adjusted indirect treatment comparison of the bioavailability of WHO-prequalified first-line generic antituberculosis medicines.Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment.Rifampicin in Nontuberculous Mycobacterial Infections: Acute Kidney Injury with Hemoglobin Casts.Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.Pharmaceutical quality assurance of local private distributors: a secondary analysis in 13 low-income and middle-income countries.Quality of medicines in resource-limited settings: need for ethical guidance
P2860
Q24658634-CDA3A6F2-095B-4B7F-B715-F0E346E88383Q30376760-81283000-0F1C-45F4-8552-11107446844CQ30377168-0F8CE598-A446-4B34-92AD-BF15F06DD840Q30380209-AA8CCAE1-8D6D-4F6C-A3BC-430311DA79D1Q35606106-16E64A48-7A58-4B50-AE45-C540EA25B419Q35606112-E7B52953-F644-4150-8730-A97F2B717B6EQ36194240-37768406-9E01-49DF-863A-9B6D812F14ECQ40322708-FBD72299-E825-4E8B-B6C6-5C51D24E3B80Q40656632-20EF8B2B-571E-47CD-8499-1B002E6E506FQ42329781-75245A1A-5F91-4B1A-8427-D76D30EFD84DQ42370094-A5B818FB-5675-4923-94A5-B804EF2D84F5Q46449329-FFCEBB85-25AF-4DCA-ADB4-38C341C64EEBQ55032202-6D29E017-2CC7-44DB-B70B-00FCB858C5B4Q55282535-2F5B811B-7C68-4A21-9B30-19CE79D029DFQ55399775-E13DFD71-C675-4E02-B9FD-BE4B78730F34Q55422283-ACCAA6EC-1A6E-4583-A61B-1D015B37E955Q58657032-84E5C7B9-D296-4D39-B25B-5F369B5E321E
P2860
A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A quiet revolution in global p ...... cation of Medicines Programme.
@en
A quiet revolution in global p ...... cation of Medicines Programme.
@nl
type
label
A quiet revolution in global p ...... cation of Medicines Programme.
@en
A quiet revolution in global p ...... cation of Medicines Programme.
@nl
prefLabel
A quiet revolution in global p ...... cation of Medicines Programme.
@en
A quiet revolution in global p ...... cation of Medicines Programme.
@nl
P921
P356
P1476
A quiet revolution in global p ...... cation of Medicines Programme.
@en
P2093
Ellen F M 't Hoen
Hiiti B Sillo
P2860
P2888
P304
P356
10.1057/JPHP.2013.53
P577
2014-01-16T00:00:00Z
P5875
P6179
1000964573